Aclarion Inc. (ACON)
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA 
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
BROOMFIELD, Colo., August 05, 2025 – PRISM MediaWire – Aclarion, Inc.
Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders
Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time Broomfield, CO, July 7, 2025 – PRISM MediaWire – Aclarion, Inc.
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica Broomfield, CO, April 2, 2025 – PRISM MediaWire – Aclarion, Inc.
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
Meeting adjourned to Wednesday, March 5, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo.
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
Broomfield, CO, February 4, 2025 – PRISM MediaWire – Aclarion, Inc.
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference
BROOMFIELD, Colo., January 31, 2025 – PRISM MediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the Selby Spine Conference.
Aclarion (ACON) Upgraded to Buy: Here's What You Should Know
Aclarion (ACON) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
BROOMFIELD, CO / ACCESSWIRE / November 14, 2024 / Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq:ACON)(Nasdaq:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced its participation at the upcoming Virtual Investor Summit Microcap Event on November 21st. The Company will be available for 1-on-1 meetings throughout the day in addition to its formal presentation.
Aclarion Added to PRISM Emerging Medical Devices Index
NEW YORK, September 06, 2024 – PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ: ACON) has been added to the PRISM Emerging Medical Devices Index, which highlights companies at the forefront of innovation and market disruption in the medtech sector.
